On April 7, 2023, Genome & Company closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,640 KRW | +15.73% |
|
+13.41% | -22.82% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,560 KRW | +0.82% | +5.77% | 3.33B | ||
9,640 KRW | +15.73% | +13.41% | 91.92M | ||
1st Jan change | Capi. | |
---|---|---|
-22.82% | 91.92M | |
+24.25% | 47.96B | |
+0.09% | 42.45B | |
+43.96% | 41.47B | |
+26.15% | 31.6B | |
+19.31% | 28.63B | |
-4.47% | 28.03B | |
+51.67% | 14.56B | |
+43.83% | 14.14B | |
+1.91% | 12.58B |
- Stock Market
- Equities
- A314130 Stock
- News Genome & Company
- Genome & Company announced that it has received KRW 23 billion in funding from a group of investors